Merck Begins Cuts With Manufacturing, More Cost Reductions To Follow
This article was originally published in The Pink Sheet Daily
Executive Summary
The company suggests future restructuring efforts could address R&D, marketing and sales after unveiling the first phase of its restructuring initiative.
You may also be interested in...
Merck Aims To Duplicate Januvia Launch Success In 2007
Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.
Merck Aims To Duplicate Januvia Launch Success In 2007
Launches for Janumet, Arcoxia and Emend IV are keys to continuing the momentum of firm’s turnaround plan, CEO Clark says.
Merck Cost Cuts Round Two: Sales & Marketing Take A Hit
Company announces additional $1 bil. in savings, mostly from reductions in marketing and administrative costs.